241 related articles for article (PubMed ID: 25815345)
1. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response.
Trabanelli S; Lecciso M; Salvestrini V; Cavo M; Očadlíková D; Lemoli RM; Curti A
J Immunol Res; 2015; 2015():253191. PubMed ID: 25815345
[TBL] [Abstract][Full Text] [Related]
2. The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.
Trabanelli S; Očadlíková D; Ciciarello M; Salvestrini V; Lecciso M; Jandus C; Metz R; Evangelisti C; Laury-Kleintop L; Romero P; Prendergast GC; Curti A; Lemoli RM
J Immunol; 2014 Feb; 192(3):1231-40. PubMed ID: 24391212
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
[TBL] [Abstract][Full Text] [Related]
4. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.
Catani L; Sollazzo D; Trabanelli S; Curti A; Evangelisti C; Polverelli N; Palandri F; Baccarani M; Vianelli N; Lemoli RM
Ann Hematol; 2013 Jan; 92(1):67-78. PubMed ID: 22936460
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
Front Immunol; 2018; 9():950. PubMed ID: 29867939
[TBL] [Abstract][Full Text] [Related]
7. LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.
Kim NS; Torrez T; Langridge W
Cell Immunol; 2019 Apr; 338():32-42. PubMed ID: 30910218
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib Exerts
Ocadlikova D; Lecciso M; Broto JM; Scotlandi K; Cavo M; Curti A; Palmerini E
Front Immunol; 2021; 12():577766. PubMed ID: 33717062
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells.
Iachininoto MG; Nuzzolo ER; Bonanno G; Mariotti A; Procoli A; Locatelli F; De Cristofaro R; Rutella S
Molecules; 2013 Aug; 18(9):10132-45. PubMed ID: 23973990
[TBL] [Abstract][Full Text] [Related]
10. The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.
Jochems C; Fantini M; Fernando RI; Kwilas AR; Donahue RN; Lepone LM; Grenga I; Kim YS; Brechbiel MW; Gulley JL; Madan RA; Heery CR; Hodge JW; Newton R; Schlom J; Tsang KY
Oncotarget; 2016 Jun; 7(25):37762-37772. PubMed ID: 27192116
[TBL] [Abstract][Full Text] [Related]
11. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
[TBL] [Abstract][Full Text] [Related]
12. CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1.
Očadlíková D; Trabanelli S; Salvestrini V; Ciciarello M; Evangelisti C; Lecciso M; Sabattini E; Righi S; Piccioli M; Pileri SA; Lemoli RM; Curti A
Exp Hematol; 2015 Apr; 43(4):268-76.e5. PubMed ID: 25584868
[TBL] [Abstract][Full Text] [Related]
13. Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.
Mbongue JC; Nicholas DA; Zhang K; Kim NS; Hamilton BN; Larios M; Zhang G; Umezawa K; Firek AF; Langridge WH
PLoS One; 2015; 10(2):e0118562. PubMed ID: 25714914
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK
J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533
[TBL] [Abstract][Full Text] [Related]
15. The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect.
Shimabukuro-Vornhagen A; Liebig TM; Koslowsky T; Theurich S; von Bergwelt-Baildon MS
Cell Immunol; 2013 Jan; 281(1):62-7. PubMed ID: 23454682
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
[TBL] [Abstract][Full Text] [Related]
17. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition.
von Bergwelt-Baildon MS; Popov A; Saric T; Chemnitz J; Classen S; Stoffel MS; Fiore F; Roth U; Beyer M; Debey S; Wickenhauser C; Hanisch FG; Schultze JL
Blood; 2006 Jul; 108(1):228-37. PubMed ID: 16522817
[TBL] [Abstract][Full Text] [Related]
18. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.
Schulz S; Landi A; Garg R; Wilson JA; van Drunen Littel-van den Hurk S
Clin Exp Immunol; 2015 Jun; 180(3):484-98. PubMed ID: 25605587
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.
Toniolo PA; Liu S; Yeh JE; Moraes-Vieira PM; Walker SR; Vafaizadeh V; Barbuto JA; Frank DA
J Immunol; 2015 Apr; 194(7):3180-90. PubMed ID: 25725100
[TBL] [Abstract][Full Text] [Related]
20. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
